perindopril oor Spaans
perindopril
en
A long-acting ACE inhibitor.
Vertalings in die woordeboek Engels - Spaans
perindopril
Generic entry for products like perindopril typically leads to two notable changes in the market.
La entrada de genéricos como el perindopril normalmente conduce a dos cambios importantes del mercado.
Geskatte vertalings
Vertoon algoritmies gegenereerde vertalings
voorbeelde
Advanced filtering
Voorbeelde moet herlaai word.
((Competition - Agreements, decisions and concerted practices - Market for perindopril, a medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions - Decision finding an infringement of Article 101 TFEU - Patent dispute settlement agreement - Administrative procedure - Legal professional privilege protecting communications between lawyers and their clients - Potential competition - Restriction of competition by object - Objective necessity of the restriction - Balance between competition law and patent law - Conditions for exemption under Article 101(3) TFEU - Fines - 10 % cap - Imputation of the unlawful conduct))
La razón porque mi padre se peda tanto en la iglesia los domingos... es por el gran contenido de sulfuro en los frijoles cocinadosEurlex2019 Eurlex2019
Coversyl and associated names contain perindopril, a well-known, potent angiotensin converting enzyme inhibitor (ACE-I), marketed in France as Coversyl # and # mg since #, the entire European Union, and world-wide in more than # countries including USA and Japan
Un mensajero estadounidense, SamirEMEA0.3 EMEA0.3
The Perindopril (Servier) decision concerns (i) five patent settlement agreements between Servier (2), an originator pharmaceutical producer company, and five generic producers (2005-2007); and (ii) a technology acquisition by Servier (2004), which sought to delay generic entry in the perindopril market, a medicine to treat cardiovascular diseases.
Cuando se diluye Filgrastim ratiopharm en una solución para perfusión de glucosa # mg/ml (al # %), es compatible con el vidrio y diversos plásticos como PVC, poliolefina (copolímero de polipropileno y polietileno) y polipropilenoEurLex-2 EurLex-2
Half of the participants received a fixed combination of two blood pressure-lowering drugs (perindopril and indapamide) in a single tablet, daily.
Concejal Banks, mis clientes han sido más que accesiblescordis cordis
Servier's exclusionary strategy aimed at removing the closest sources of competition to its branded perindopril.
Tiene la palabra el Sr. Schulz.EurLex-2 EurLex-2
Application under Article 263 TFEU for annulment of Commission Decision C(2014) 4955 final of 9 July 2014 relating to a proceeding under Article 101 and Article 102 TFEU [Case AT.39612 — Perindopril (Servier)] in so far as it concerns the applicants and, in the alternative, for reduction of the fine imposed on the applicants by that decision.
Después de treinta años en la fuerza, Cross pierde su reputación, su pensión, él es despedidoEuroParl2021 EuroParl2021
Servier was found to be dominant on the market for perindopril in the United Kingdom, France, the Netherlands and Poland, for the period starting in 2000 and ending between 2007 and 2009 (depending on the specific national market).
Tratamiento arancelario favorableEurLex-2 EurLex-2
After oral administration, the absorption of perindopril is rapid and the peak concentration complete within # hour
Fila inicialEMEA0.3 EMEA0.3
((Competition - Agreements, decisions and concerted practices - Market for perindopril, a medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions - Decision finding an infringement of Article 101 TFEU - Patent dispute settlement agreement - Potential competition - Restriction of competition by object - Balance between competition law and patent law - Imputation of the unlawful conduct - Fines))
En ese momento se abrirán las ventanillas y el maletero del vehículo, si todavía no se han abiertoEurlex2019 Eurlex2019
Application under Article 263 TFEU for annulment of Commission Decision C(2014) 4955 final of 9 July 2014 relating to a proceeding under Article 101 and Article 102 TFEU [Case AT.39612 — Perindopril (Servier)] in so far as it concerns the applicants and, in the alternative, for annulment or reduction of the fine imposed on the applicants by that decision.
Eso es buenoEuroParl2021 EuroParl2021
((Competition - Agreements, decisions and concerted practices - Perindopril market, medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions - Decision finding an infringement of Article 101 TFEU - Principle of impartiality - Consultation of the Advisory Committee on Restrictive Practices and Dominant Positions - Patent dispute settlement and exclusive purchasing agreement - Potential competition - Restriction of competition by object - Balance between competition law and patent law - Conditions for exemption under Article 101(3) TFEU - Fines))
Sólo un momentoEurlex2019 Eurlex2019
In 2014, the Commission imposed fines totalling EUR 427.7 million on the French pharmaceutical company Servier and five producers of generic medicines (Niche/Unichem, Matrix/Mylan, Teva, Krka and Lupin) for concluding a series of deals aimed to protect Servier’s bestselling blood pressure medicine, perindopril, from price competition by generics in the EU 40 .
Ahora me da o mi KEurlex2019 Eurlex2019
((Competition - Agreements, decisions and concerted practices - Market for perindopril, a medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions - Decision finding an infringement of Article 101 TFEU - Patent dispute settlement agreement - Commission’s territorial jurisdiction - Imputation of the unlawful conduct - Administrative procedure - Legal professional privilege protecting communications between lawyers and their clients - Potential competition - Restriction of competition by object - Objective necessity of the restriction - Balance between competition law and patent law - Conditions for exemption under Article 101(3) TFEU - Fines))
A llamar a unmédico.- ¿ Qué?Eurlex2019 Eurlex2019
The combination of perindopril and potassium sparing diuretics, potassium supplements or potassium-containing salt substitutes is generally not recommended (see # Interaction with other medicinal products and other forms of interaction
¿ No quieres enseñarle tu okapi a la abuela?- ¡ Okapi!- ¡ Si!EMEA0.3 EMEA0.3
Application under Article 263 TFEU for annulment of Commission Decision C(2014) 4955 final of 9 July 2014 relating to a proceeding under Article 101 and Article 102 TFEU [Case AT.39612 — Perindopril (Servier)] in so far as it concerns the applicant and, in the alternative, for annulment or reduction of the fine imposed on the applicant by that decision.
M. Meulenbelt y H. Speyart, abogadosEuroParl2021 EuroParl2021
Servier's exclusionary strategy, implemented through the aforementioned six transactions concluded within the space of 27 months, thus constitutes a single and continuous infringement of Article 102 of the Treaty in the period 2004-2009 on the market for perindopril formulations in the United Kingdom, France, the Netherlands and Poland, and on the EU market for perindopril API technology.
A mi hermana alejaránEurLex-2 EurLex-2
((Competition - Agreements, decisions and concerted practices - Market for perindopril, a medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions - Decision finding an infringement of Articles 101 TFEU and 102 TFEU - Agreements intended to delay, or even prevent, the market entry of generic versions of perindopril - Participation of a subsidiary in the infringement committed by its parent company - Imputation of the infringement - Joint and several liability - Ceiling of the fine))
las demás denominaciones bajo las que todavía se comercializan las semillas de la variedad (antiguas variedadesEurlex2019 Eurlex2019
Annuls Article 4 of Commission Decision C(2014) 4955 final of 9 July 2014 relating to a proceeding under Article 101 and Article 102 TFEU (Case AT.39612 — Perindopril (Servier)) in so far as it finds that Krka Tovarna Zdravil d.d. participated in the agreements referred to in that article;
Y yo creí que cambiarías si cambiaba yoEurlex2019 Eurlex2019
More patients withdrew for cough, hypotension or other intolerance on perindopril than on placebo, # % (n=#) versus # % (n=#) respectively
Buenas nochesEMEA0.3 EMEA0.3
Perindopril should be used with extreme caution in patients with collagen vascular disease, immunosuppressant therapy, treatment with allopurinol or procainamide, or a combination of these complicating factors, especially if there is pre-existing impaired renal function
Festus, vamos ha celebrar un torneo deportivoEMEA0.3 EMEA0.3
Case T-684/14: Judgment of the General Court of 12 December 2018 — Krka v Commission (Competition — Agreements, decisions and concerted practices — Market for perindopril, a medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions — Decision finding an infringement of Article 101 TFEU — Patent dispute settlement agreement — Licensing agreement — Technology acquisition agreement — Restriction of competition by object — Restriction of competition by effect — Balance between competition law and patent law)
¿ Se considera un buen marido?Eurlex2019 Eurlex2019
In cases of renal impairment (creatinine clearance < # ml/min) the initial perindopril dosage should be adjusted according to the patient s creatinine clearance (see # Posology and method of administration) and then as a function of the patient s response to treatment
Alguien que tiene larespuestaEMEA0.3 EMEA0.3
((Competition - Agreements, decisions and concerted practices - Market for perindopril, a medicinal product intended for the treatment of cardiovascular diseases, in its originator and generic versions - Decision finding an infringement of Article 101 TFEU - Patent dispute settlement agreement - Licensing agreement - Technology acquisition agreement - Restriction of competition by object - Restriction of competition by effect - Balance between competition law and patent law))
Hay más hombres en el mundoEuroParl2021 EuroParl2021
This case concerns patent settlement agreements between the originator pharmaceutical producer Servier and five generic producers between 2005 and 2007 and a technology acquisition by Servier in 2004 in connection with the manufacture and sale of perindopril, a medicine to treat cardiovascular diseases.
Tienen miedo de ello y quieren que Europa les ayude a superar sus desventajas.EurLex-2 EurLex-2
204 sinne gevind in 14 ms. Hulle kom uit baie bronne en word nie nagegaan nie.